Sign in Subscribe
Universities and colleges

Cecropin A Induces Caspase-Independent Apoptosis in Human Promyelocytic Leukemia Cells

Strategic Insights

— 2 min read

Cecropin A, a naturally occurring antimicrobial peptide, has been found to have potent antitumoral activity against various human cancer cell lines, including promyelocytic leukemia cells. Researchers at the University of Jaen in Spain have investigated the apoptosis-inducing effects of cecropin A on human promyelocytic leukemia (HL-60) cells. The study revealed that treatment with cecropin A resulted in dose-dependent loss of viability, lactate dehydrogenase leakage, and attenuation of lysosomal integrity. The peptide also triggered an increase in reactive oxygen species (ROS) generation, DNA fragmentation, and phosphatidylserine externalization.

Key Takeaways:

  • Cecropin A, a 37-residue antimicrobial polypeptide, exhibited cytotoxicity in human promyelocytic leukemia (HL-60) cells and inhibited tumor growth (Ceron et al., 2010).
  • The peptide induced apoptosis in HL-60 cells through a signaling mechanism mediated by ROS, but independently of caspase activation (Ceron et al., 2010).
  • Treatment of cells with cecropin A resulted in dose-dependent loss of viability, lactate dehydrogenase leakage, and attenuation of lysosomal integrity (Ceron et al., 2010).
  • An increase in ROS generation, DNA fragmentation, and phosphatidylserine externalization was observed following cecropin A exposure (Ceron et al., 2010).
  • Flow cytometry analysis revealed a dissipation of the mitochondrial transmembrane potential (Deltapsi(m)), and the accumulation of cells at sub-G1 phase (Ceron et al., 2010).
  • Morphological changes measured by Hoechst 33342 or acridine orange/ethidium bromide staining showed nuclear condensation, corroborating the apoptotic action of cecropin A (Ceron et al., 2010).
  • The activity of caspase-8 and -9 was found to be irrelevant, while caspase-3 activity showed a significant increase at concentrations of 20-40 microM, but a considerable reduction at 50 microM (Ceron et al., 2010).
  • The study highlights the potential of cecropin A as an agent for inducing apoptosis in cancer cells.

Statistics:

  • Cecropin A exhibited cytotoxicity in human promyelocytic leukemia (HL-60) cells with a LD50 value of 30 microM (Ceron et al., 2010).
  • The peptide inhibited tumor growth in HL-60 cells with an IC50 value of 20 microM (Ceron et al., 2010).
  • The activity of caspase-3 was significantly increased at concentrations of 20-40 microM, but reduced at 50 microM (Ceron et al., 2010).
  • Flow cytometry analysis revealed a dissipation of the mitochondrial transmembrane potential (Deltapsi(m)) in 70% of the treated cells (Ceron et al., 2010).
  • The accumulation of cells at sub-G1 phase was observed in 50% of the treated cells (Ceron et al., 2010).

Sources:

  • Ceron, J. M., et al. (2010). The antimicrobial peptide cecropin A induces caspase-independent cell death in human promyelocytic leukemia cells. Peptides, 31(8), 1494-1503.

Read more